key: cord-0427806-y7l4cbet authors: Baysal, Bora E.; Tabaczynski, Debra; Curtin, Leslie; Seshadri, Mukund; Sexton, Sandra title: Partial loss of succinate dehydrogenase reduces high red cell distribution width and promotes healthy survival in chronically hypoxic mice date: 2021-05-19 journal: bioRxiv DOI: 10.1101/2021.05.18.444547 sha: 4eb4a1c4e319a9319a4b5b2316659a27ff70dec9 doc_id: 427806 cord_uid: y7l4cbet Increased red cell distribution width (RDW), which measures erythrocyte size variability (anisocytosis), has been linked to early mortality in many diseases and normal aged population through unknown mechanisms. Hypoxia has been proposed to increase both RDW and mortality. However, experimental evidence, especially in animal models, is lacking. Here, we show that chronic hypobaric hypoxia (~10% O2) increases erythrocyte numbers, hemoglobin and RDW, while reducing longevity in male mice. Compound heterozygous knockout (chKO) mutations in succinate dehydrogenase (Sdh; mitochondrial complex II) genes Sdhb, Sdhc and Sdhd reduce high RDW and immature reticulocyte fraction, and increase healthy lifespan in chronic hypoxia. Hemoglobin and erythrocyte numbers in hypoxia do not show statistically significant differences between Sdh chKO and WT mice. These results identify a mitochondrial mechanism regulating both RDW and organismal adaptation to chronic hypoxia, and suggest SDH as a potential therapeutic target to reduce high RDW-associated clinical mortality. Erythrocyte anisocytosis refers to increased variation in red blood cell (RBC) size, and is measured by red cell distribution width (RDW) in routine complete blood count (CBC) analysis. RDW is often reported as a coefficient of variation (RDW-CV) of erythrocyte mean corpuscular volume (MCV) in RBC volume distribution curve. RDW-CV is calculated by dividing the standard deviation (SD) by MCV, multiplied by 100. RDW-SD is a direct measure of anisocytosis that reports the MCV variation at 20% frequency level [1] . RDW increases in healthy aging population [2] . RDW along with MCV was traditionally used in the differential diagnosis of anemia. In recent years, however, high RDW has been associated with increased mortality in acute and chronic diseases as well as in middle-aged and older individuals without disease [3, 4] . The association has been observed in a growing list of clinical conditions including heart failure [5, 6] , myocardial infarction [7] , peripheral artery disease [8] , cancer [9] , pulmonary hypertension [10] , acute pulmonary embolism [11] , community-acquired pneumonia [12, 13] , SARS-CoV-2 infection [14] , chronic obstructive pulmonary disease [15, 16] [27] , and kidney transplant receivers [28] . The underlying mechanism(s) for this association is unknown. Although anisocytosis is a physiologic response to anemia, the association with mortality in nonanemic individuals remains significant [29] [30] [31] [32] [33] [34] , and becomes even stronger than seen in anemic individuals in meta-analysis [35] . A correlation between inflammatory markers and anisocytosis has been documented, which raises the hypothesis that RDW effect on mortality may be mediated by systemic inflammation [36] . However, the association of anisocytosis with mortality and disease remains statistically significant even in subjects with low inflammatory marker CRP levels [4, 37, 38] . It has been hypothesized that RBCs with increased size variation may have reduced deformability that impairs micro-circulatory blood flow, though contrasting results were reported on the impact of increased RDW on RBC deformability [39, 40] . Furthermore, certain anemias cause anisocytosis without significantly increasing the mortality risk. For example, dietary iron deficiency anemia is attributed to ~0.08 deaths per 100,000 [41] . These considerations collectively suggest that the mortality risk associated with anisocytosis cannot be readily explained by anemia, inflammation or RBC physicochemical characteristics. Increased anisocytosis may reflect a fundamental cellular pathology that predisposes to mortality regardless of the specific clinical condition. Yčas et al. analyzed over 2 million medical claims and concluded that RDW indicates systemic hypoxic load, especially in pulmonary and cardiac conditions [42] . High RDW correlates with severity and poor survival in COPD [15, 16, 43 , 44] as well as with lung function in normal subjects [45] . A recent analysis of RDW in 121,530 non-anemic individuals with a medical condition revealed the strongest associations with pulmonary hypertension, chronic pulmonary heart disease and congestive heart failure, which all have a pathophysiologic link to hypoxia [46] . Similarly both hypoxemia and high RDW have been linked to mortality risk in COVID-19 patients [14, 47] . Hypoxia triggers the production of RBC precursor reticulocytes from bone marrow through the operation of PhD-HIF pathway that regulates erythropoietin production [48] . Since reticulocytes are larger than mature RBCs, anisocytosis ensues. Thus, systemic hypoxia appears to be a biologically plausible factor that might explain the association between anisocytosis and mortality. However, experimental evidence for this hypothesis is lacking. In this study, we report on the impact of chronic hypobaric hypoxia on RBC parameters and survival in Sdh heterozygous and wild-type control male mice. In humans, heterozygous germline SDH subunit mutations predispose to paraganglioma (PGL) and pheochromocytoma tumors [49] . Hereditary PGL tumors caused by SDHD mutations often develop in the carotid body (CB) in neck [50] , and mimic the sporadic CB paragangliomas caused by chronic hypoxic stimulation of high altitudes [51] . Higher altitude increases the severity of hereditary PGL tumors [52, 53] . Gene expression profiling studies in SDH PGLs show persistent activation of hypoxiainduced genes in normoxic conditions (pseudo-hypoxia) [54] . These results collectively suggest that SDH mutations predispose to PGL tumors by constitutively activating the hypoxiasensing/signaling pathways in paraganglionic tissues. Sdh mouse models show that while homozygous deficiency of a subunit is incompatible with normal life and development, heterozygous mutations do not cause paraganglioma tumors [55] . Here, we present evidence that chronic hypoxic stimulation also fails to develop paraganglioma tumors in Sdh mice. We find that mice with partial Sdh deficiency show reduced RDW and increased survival relative to control mice in chronic hypoxia, revealing an unexpected mechanism contributing to the association between high RDW and mortality. The experimental mice were derived by crossing three previously described original strains each containing a heterozygous knockout mutation in a distinct Sdh subunit (Sdhb, Sdhc or Sdhd). Sdhb and Sdhc heterozygous KO mice were created in The Jackson Laboratory (Bar Harbor, Maine) in B6/129P2 background [56] . The original strains are described as: B6.129P2-Sdhb/Cx and B6.129P2-Sdhc/Cx. Sdhd knockout mouse [57] was re-derived into C57BL/6J background at RPCCC transgenic facilities using frozen sperm (mfd Diagnostics, Germany). As previously reported, homozygous mutations in any subunit are non-viable, but compound Sdhb/Sdhc double heterozygous and Sdhb/Shdc/Sdhd triple heterozygous KO mice are viable [56] . Since each gene is located on a different mouse chromosome, the KO alleles segregate independently and give the expected numbers of each viable genotype upon crossing Sdh hKO mice. Control WT mice were also derived from crosses of Sdh hKO mice. WT controls were either littermates or from closely related litters. If WTs Genotyping was performed in tail tips at RPCCC transgenic facility as described [56] . Genotypes of the mice in hypoxia chamber are confirmed by repeat testing. Mice were exposed to chronic hypobaric hypoxia in a custom-made hypoxia chamber (Case Western Reserve University Design Fabrication Center, Cleveland, OH) that operates via house vacuum and accommodates 2 standard mice cages, as previously described [56] . Mice were initially subjected mild hypoxia (~15%) for ~1 week for acclimatization. For chronic exposure. the oxygen concentration was ~10% with a range of 9-11%, due to house vacuum oscillations. Oxygen percentage is continuously monitored by an O2 sensor. Hypoxia exposure experiments involved 5 compound heterozygous and 5 WT control mice, with each genotypic group placed in a different cage after ~ 10 weeks of age. Mice were daily observed, and briefly removed from the chamber twice a week for cage cleaning. Mice remained in hypoxia chamber until spontaneous death or the development of morbid conditions, as assessed during cage cleaning, that required euthanasia in accordance with Roswell animal care guidelines and the approved IACUC protocol. Examples of morbid conditions included limited or absent movement, hunched posture, labored breathing, sunken eyes, shaking and development of rectal prolapse. All decisions for euthanasia due to morbid status were made in accordance with approved IACUC guidelines. Organs were grossly examined during necropsy. Tissues were collected upon spontaneous death and euthanasia. Periodically, body weights were measured and blood was collected for CBC analysis. Blood The development of PGL or other tumors was prospectively examined in 3 sequentially tested groups of male mice exposed to lifelong hypoxia (~10% O2). Group 1 had Sdh double hKO of Sdhb and Sdhc, whereas Groups 2 and 3 had Sdh triple hKO of Sdhb, Sdhc and Sdhd ( Table 1 ). The initial goal was to determine whether compound heterozygosity in Sdh predisposes to PGL tumor development under chronic hypoxia. MRI analysis of 1 chKO Sdh bc (#145) and 1 WT control (#197) mouse after ~7 months of chronic hypoxia exposure showed no MRI evidence of tumor development in either genotype (Supp Fig. 1 ). Gross and microscopic examination of the hypoxia-exposed mice showed no evidence of tumor development or vascular pathology including intimal thickening or plexiform lesions in lung or pheochromocytoma development in adrenal gland (Supp. Fig. 2) . Thus, although hypobaric hypoxia of high altitudes promotes development of sporadic paragangliomas in humans, we find no evidence of Sdh-related PGL tumor development in mice both in normoxia and hypoxia. We observed mice until spontaneous death or development of morbidities that require euthanasia to increase the possible risk of hypoxia-induced paraganglioma development. Healthy lifespans of mice in chronic hypoxia (median 503 days for Sdh chKO and 456 days for WT control) were substantially lower than that of the parental B6 mice living in room conditions (~ 2.5 years). However, we found that Sdh chKO mice survived longer than WT control mice in each of the 3 experimental groups ( Table 1) . When data from 3 groups were combined, the lifespan differences between Sdh chKO and WT mice were statistically significant (P<0.0001 by Log-rank (Mantel-Cox) test and P=0.0024 by Gehan-Breslow-Wilcoxon test. Fig.1 Necropsy of mice revealed no specific causes to explain early death or development of moribund conditions, but showed congestion and enlarged spleen and heart which are expected under chronic hypoxia. Chronic hypoxia is associated with the development of pulmonary hypertension and right ventricular hypertrophy. We assessed right ventricular hypertrophy by Fulton index in experimental group 2, and found no statistically significant differences between Sdh and WT control mice (Supp. Fig. 3) . This result suggests that pulmonary hypertension differences do not probably explain the differential survival between the Sdh chKO and WT mice. To examine whether erythrocyte numbers could explain the survival differences between the two genotypes, we analyzed CBC variables from 3 groups of Sdh hKO male mice and WT controls using 2way ANOVA test. No statistically significant differences were observed in erythrocyte numbers or hemoglobin (HGB) levels in any group ( Fig. 2A) . Reduced hematocrit (HCT) ( Fig. 2A) , mean corpuscle volume (MCV), mean corpuscular hemoglobin (MCH) (Fig. 2B ), RDW-CV (Fig. 2C) , reticulocyte percentage (Ret%) and immature reticulocyte fraction (IRF) (Fig. 2D) were also observed Sdh chKO mice in 1 of 3 groups (Fig. 2) . The most statistically significant differences between the genotypes were observed in RDW-SD and 1SD-RDW which showed a reduction in Sdh chKO mice in 2 of 3 groups (Fig. 2C) . Analysis of the combined data from all 3 groups showed the most statistically significant differences in RDW-SD, RDW-CV, 1SD-RDW and IRF both in normoxia and hypoxia with lower values observed in Sdh chKO mice relative to WT control mice ( Table 2) . Borderline statistically significant differences were seen in hematocrit and MCV in hypoxia and reticulocyte percentage in normoxia. No statistically significant differences were seen in the numbers of white blood cells, platelets and in platelet distribution width (PDW) between Sdh hKO and WT mice in normoxia or hypoxia ( Fig. 2E and Table 2) . Collectively, the differences in CBC parameters point to reduced erythropoietic activity and RBC regeneration by partial loss of Sdh, especially in hypoxia. In this study, we show that chKO mutations in Sdh genes prolong healthy survival by ~10% under chronic hypoxia and reduce multiple measures of RBC anisocytosis including RDW-SD, RDW-CV and 1SD-RDW. Other parameters related to RBC regeneration including IRF, HCT and MCV also show evidence of reductions in Sdh KO mice compared to WT. We find no evidence of PGL tumor development in mice even with chronic lifelong hypoxia exposure, in agreement with a recent study [58] . These findings collectively show a previously unrecognized role for Sdh in regulation of erythroid regeneration both in normoxia and hypoxia. To our knowledge, this is also the first mammalian study showing a hypoxia-survival benefit upon partial constitutional loss of Sdh, suggesting a role for Sdh in cellular and organismal adaptation to hypoxia in mice. Detailed studies in Ascaris Suum, a helminthic parasite, show that Sdh is active in spore forms which respire atmospheric O2, but inactive in the adult forms which live in the hypoxic environment of the host intestine. The adult parasite instead uses fumarate reductase (Frd), which catalyzes the reverse reaction of Sdh [59] . A hypoxic switch in Sdh genes also controls respiration in Mycobacterium Tuberculosis [60] . ATP producing eukaryotic mitochondria use Frd rather than Sdh under limited O2 conditions [61] . Flies resistant to hypoxia have reduced complex II activity levels compared to the control flies [62] . Anoxic environments (N2 or CO2) lead to decreased transcript expression of the 3 of four SDH subunit genes, by promoter methylation in maize [63] . Our findings combined with these studies suggest that inhibition of Sdh is a universal theme in organismal adaptation to hypoxia/anoxia across diverse organisms including mammals. Identification of the molecular mechanisms linking reduced Sdh to organismal tolerance to hypoxia requires further studies. There is already evidence that loss of SDH triggers hypoxia adaptation pathways in human PGL tumors. The SDHD gene is subject to maternal imprinting (inactivation) in hypoxia-sensitive carotid body chief cells, because only a paternal transmission, but not maternal transmission, of the mutated SDHD gene predisposes to paraganglioma tumors. This finding raises the hypothesis that partial loss of SDH activity by genomic imprinting is physiologically employed to facilitate hypoxia sensing and/or adaptation in carotid body cells [64] . We recently showed that inhibition of complex II by atpenin A5 triggers hypoxic gene expression and RNA editing by APOBEC3A and APOBEC3G cytidine deaminases independently of HIF1 in monocytes and natural killer (NK) cells, respectively [56, 65] . The SDHB and SDHA genes acquire nonsense/missense RNA editing by APOBEC3A in monocytes subjected to cellular crowding and hypoxia [66, 67] . RNA editing by APOBEC3G in NK cells is induced by cellular crowding and hypoxia and promotes Warburg-like metabolic remodeling by suppressing O2 consumption relative to glycolysis [65] . Perhaps, the inhibition of Sdh in mice activates similar HIF-independent hypoxia-adaptation pathways including gene expression, and RNA editing, and possibly other adaptive pathways that remain to be discovered. Importantly, our findings show a mitochondrial basis for the association between high RDW and mortality. Previous research has established that inhibition of mitochondrial respiration antagonizes the hypoxic stabilization of HIF-α [68, 69] , the key molecular event driving the synthesis of erythropoietin that stimulates RBC regeneration in bone marrow. Pharmacologic inhibition of complex II by atpenin A5 reduces the stabilization of HIF-α in cancer cell lines in hypoxia, and reduces baseline O2 consumption [56, 70] . Atpenin A5 is a highly potent complex II inhibitor of ubiquinone binding that occurs at the interface of Sdhb, Sdhc and Sdhd subunits [71, 72] . Therefore, we suggest that partial loss of Sdh in hKO mice reduces mitochondrial O2 consumption and dampens HIF-mediated erythropoietic activity, leading to reduced RDW in hypoxia. Our study has certain limitations including the lack of a specific heart or lung disease in which high RDW has been associated with early mortality in clinical studies, and indeterminate cause of death in hypoxic mice. Also, these findings remain to be extended to female mice. Further studies are required to close these knowledge gaps in the future. In summary, our findings provide evidence that Sdh plays a role in regenerative erythrocyte anisocytosis and organismal survival in mice under chronic hypoxia. Our data support a model that upon systemic hypoxia, continued mitochondrial O2 consumption leads to cellular O2 deprivation, increased erythropoiesis and high RDW. This unchecked O2 consumption ultimately exhausts intracellular O2 to cause cellular injury, organ failure and death. Suppressing Sdh reduces O2 consumption, mitigates cellular hypoxia, blunts RDW increase and triggers HIFindependent hypoxia adaptation pathways to promote organismal tolerance to chronic hypoxia (Fig.3) . We hypothesize that high RDW is merely a surrogate biomarker for organismal hypoxia which is regulated by mitochondrial O2 consumption and is the ultimate driver of cell death, organ failure and mortality. Therefore, therapeutic targeting of SDH may be beneficial to reduce high RDW-associated mortality in hypoxic diseases by enhancing systemic adaptation to hypoxia. WT and n=15 chKO) . The curve differences are statistically significant by Log-rank (Mantel-Cox) and Gehan-Breslow-Wilcoxon tests. Survival is measured by the total number of days until spontaneous death or the development of morbidities that require euthanasia (Table 1 ) in chronic hypoxia. Four WT and eight chKO mice are censored from the analysis since these mice did not complete the hypoxic survival end points (See Table 1 ). BEB is an inventor in an institutional patent application. BEB is founder of a start-up company that aims to develop therapeutics based on the work described here. Red cell distribution width, revisited Red Blood Cell Distribution Width Is Significantly Associated With Aging and Gender. Clinical chemistry and laboratory medicine Red blood cell distribution width and the risk of death in middle-aged and older adults Red blood cell distribution width and mortality risk in a community-based prospective cohort Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. The American journal of cardiology Usefulness of red cell distribution width to predict mortality in patients with peripheral artery disease. The American journal of cardiology Red cell distribution width and cancer Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia. The American journal of emergency medicine Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection Uysal A, Altın S: Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease Increased red cell distribution width: A novel predictor of adverse outcome in patients hospitalized Distribution Width Identifies Key Associations with Pulmonary Hypertension Association between hypoxemia and mortality in patients with COVID-19 Erythrocytosis: the HIF pathway in control Paraganglioma and phaeochromocytoma: from genetics to personalized medicine Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma High-altitude paragangliomas diagnostic and therapeutic considerations Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect Mutation of SDHB is a cause of hypoxia-related high-altitude paraganglioma Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas Genetically modeled mice with mutations in mitochondrial metabolic enzymes for the study of cancer Mitochondrial complex II regulates a distinct oxygen sensing mechanism in monocytes The mitochondrial SDHD gene is required for early embryogenesis, and its partial deficiency results in persistent carotid body glomus cell activation with full responsiveness to hypoxia Unexpected obesity, rather than tumorigenesis, in a conditional mouse model of mitochondrial complex II deficiency Role of complex II in anaerobic respiration of the parasite mitochondria from Ascaris suum and Plasmodium falciparum Succinate dehydrogenase is the regulator of respiration in Mycobacterium tuberculosis Biochemistry and evolution of anaerobic energy metabolism in eukaryotes Hypoxia-adaptation involves mitochondrial metabolic depression and decreased ROS leakage Expression and promoter methylation of succinate dehydrogenase and fumarase genes in maize under anoxic conditions Genomic imprinting and environment in hereditary paraganglioma. American journal of medical geneticsPart C, Seminars in medical genetics Mitochondrial hypoxic stress induces widespread RNA editing by APOBEC3G in natural killer cells APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages Hypoxiainducible C-to-U coding RNA editing downregulates SDHB in monocytes A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation Mitochondria and cellular oxygen sensing in the HIF pathway Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase) Synthesis and antineoplastic evaluation of mitochondrial complex II (succinate dehydrogenase) inhibitors derived from atpenin A5 Active mitochondria Oxygen deprivation and higher RDW